Hepcidin is produced by lymphoplasmacytic cells and is associated with anemia in Waldenström's macroglobulinemia

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 1, 2011, Pages 160-163

  Ciccarelli, Bryan T ^a   Patterson, Christopher J ^a   Hunter, Zachary R ^a   Hanzis, Christina ^a   Ioakimidis, Leukothea ^a   Manning, Robert ^a   Yang, Guang ^a   Xu, Lian ^a   Zhou, Yangsheng ^a   Sun, Jenny ^a   Liu, Xia ^a   Tseng, Hsiuyi ^a   Cao, Yang ^a   Sheehy, Patricia ^a   Rodig, Scott J ^a,b   Treon, Steven P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; IMMUNOGLOBULIN M; INTERLEUKIN 6; IRON;

ADULT; AGED; ANEMIA; BONE MARROW BIOPSY; BONE MARROW DISEASE; CONFERENCE PAPER; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION PROFILING; HEMATOCRIT; HORMONE BLOOD LEVEL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; WALDENSTROEM MACROGLOBULINEMIA;

EID: 79953727571     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2011.n.038     Document Type: Conference Paper

References (18)

1. Treon SP. How I Treat Waldenstrom's macroglobulinemia. Blood 2009; 114:2375-85.
2. Fleming RE, Sly WS. Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. PNAS 2001; 98:8160-2.
3. Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276:7806-10.
4. Theurl I, Theurl M, Seifert M, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 2008; 111:2392-9.
5. Pinto JP, Dias V, Zoller H, et al. Hepcidin messenger RNA expression in human lymphocytes. Immunology 2010; 130:217-30.
6. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306:2090-3.
7. De Domenico I, Ward DM, Langelier C, et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 2007; 18:2569-78.
8. De Domenico I, Lo E, Ward DM, et al. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.PNAS USA 2009: 106:3800-5.
9. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113:1271-6.
10. Zhang X, Rovin BH. Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines. Biochim Biophys Acta 2010; 1800:1262-7.
11. Zhang AS, Gao J, Koeberl DD, et al. The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo. J Biol Chem 2010; 285:16416-23.
12. Hohaus S, Massinin G, Giachelia M, et al. Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol 2010; 28:2538-43.
13. Hatzimichael EC, Christou L, Bai M, et al. Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenström's macroglobulinemia. Eur J Haematol 2001; 66:1-6.
14. Elsawa SF, Novak AJ, Ziesmer SC, et al. Multiplex Analysis of Serum Cytokine Levels in Waldenström Macroglobulinemia Patients. Blood 2007; 110: (abstract 2616).
15. Lewicki M, Ciccarelli B, Hunter Z, et al. Comprehensive assessment of cytokines and chemokines in patients with Waldenstrom's macroglobulinemia reveals a distinct profile with pathobiological and clinical relevance. Blood 2010; 116: (abstract 1911).
16. Haurani FI, Young K, Tocantins LM. Reutilization of iron in anemia complicating malignant neoplasms. Blood 1963; 22:73-81.
17. Besa EC, Kim PW, Haurani FI. Treatment of primary iron-reutilization syndrome revisited. Ann Hematol 2000; 79:465-8.
18. Nemeth E. Development of hepcidin agonists and antagonists. Blood 2009; 114: (abstract 27).